Back to results
US 5,478,556 AGranted
Vaccination of cancer patients using tumor-associated antigens mixed with interleukin-2 and granulocyte-macrophage colony stimulating factor
OwnerRobert L. Elliott, Jonathan F. Headinventors
Life of this patent
Estimating the term…
Abstract
A breast cancer vaccine which comprises a mixture of tumor associated antigens (TAA) with low doses of recombinant interleukin-2 (IL-2) and granulocyte-macrophage colony stimulating factor (GM-CSF).
Claims3
A composition comprising 0.1 ml of a suspension containing a human breast cancer tumor associated antigen, one million colony forming units of granulocyte-macrophage colony stimulating factor, and ten thousand international units of interleukin-2.
A breast tumor vaccine comprising:
- a suspension of a tumor associated antigen from a human breast tumor;
- one million colony forming units of granulocyte-macrophage colony stimulating factor;
- and
- ten thousand international units of interleukin 2.
1 more element
Dependencies are inferred from the claim text.